Literature DB >> 18455951

Octarepeat changes of prion protein in Parkinson's disease.

Vinchi Wang1, Tzu-Chao Chuang, Bing-Wen Soong, Din-E Shan, Ming-Ching Kao.   

Abstract

Polymorphism in prion protein (PrP) is related to different phenotypes of spongiform encephalopathies and some mental illnesses. The octarepeat region of PrP, encompassing the codon 51 through 91, is related to cellular anti-oxidation function and may play a role in genetic contribution of PrP polymorphism to neurodegeneration, such as Parkinson's disease (PD). We analyzed the genomic patterns of PrP gene from 528 subjects and found a predominance of Met/Met variant at codon 129 of PD subjects without significant difference (97.3%, and 96.5% in controls). But among PD subjects there were one with heterozygosity of silent nucleotide substitution (NS) on octarepeats (R1-2-3g-3-4/R1-2-2-3-4) and three with heterozygosity of single copy deletion (CD) on octarepeats (R1-2-3-4/R1-2-2-3-4). Consistent genomic DNA and cDNA sequences were found in a PD subject without any octarepeat changes and the one with NS, but R1-2-3g-3-4/R1-2-2-3-4 of cDNA pattern occurred in the one with genomic CD. This is the first report of the polymorphic PrP octarepeat change among those with parkinsonism. We proposed a hypothesis about an initial secondary hairpin structure of the template strand followed by the transcript "shift backward" due to the high homology of the sequences between R2 and R3 motifs while synthesizing RNA. This phenomenon may be a key step of neurodegeneration resulting from PrP polymorphism and require further studies.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18455951     DOI: 10.1016/j.parkreldis.2008.03.003

Source DB:  PubMed          Journal:  Parkinsonism Relat Disord        ISSN: 1353-8020            Impact factor:   4.891


  5 in total

1.  Manganese upregulates cellular prion protein and contributes to altered stabilization and proteolysis: relevance to role of metals in pathogenesis of prion disease.

Authors:  Christopher J Choi; Vellareddy Anantharam; Dustin P Martin; Eric M Nicholson; Jürgen A Richt; Arthi Kanthasamy; Anumantha G Kanthasamy
Journal:  Toxicol Sci       Date:  2010-02-22       Impact factor: 4.849

Review 2.  Immunotherapy in prion disease.

Authors:  Yvonne Roettger; Yansheng Du; Michael Bacher; Inga Zerr; Richard Dodel; Jan-Philipp Bach
Journal:  Nat Rev Neurol       Date:  2012-12-18       Impact factor: 42.937

3.  Loss of Octarepeats in two processed prion pseudogenes in the red squirrel, Sciurus vulgaris.

Authors:  Ole Madsen; Timothy T Kortum; Marlinda Hupkes; Wouter Kohlen; Teun van Rheede; Wilfried W de Jong
Journal:  J Mol Evol       Date:  2010-09-28       Impact factor: 2.395

4.  Atypical parkinsonism caused by Pro105Leu mutation of prion protein: A broad clinical spectrum.

Authors:  Kagari Koshi Mano; Takashi Matsukawa; Jun Mitsui; Hiroyuki Ishiura; Shin-Ichi Tokushige; Yuji Takahashi; Naoko Saito Sato; Fumiko Kusunoki Nakamoto; Yaeko Ichikawa; Yu Nagashima; Yasuo Terao; Jun Shimizu; Masashi Hamada; Yoshikazu Uesaka; Genko Oyama; Go Ogawa; Jun Yoshimura; Koichiro Doi; Shinichi Morishita; Shoji Tsuji; Jun Goto
Journal:  Neurol Genet       Date:  2016-01-07

5.  A Chinese patient with the clinical features of Parkinson's disease contains a single copy of octarepeat deletion in PRNP case report.

Authors:  Qi Shi; Xiao-Jing Shen; Li-Ping Gao; Kang Xiao; Wei Zhou; Yuan Wang; Cao Chen; Xiao-Ping Dong
Journal:  Prion       Date:  2021-12       Impact factor: 3.931

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.